Adroit Biomed Ltd. Announces Innovative, Technologically Advanced, High-Performance Collagen 'Fortisil C'

May 22, 2024 06:35 AM IST | By NewsVoir
 Adroit Biomed Ltd. Announces Innovative, Technologically Advanced, High-Performance Collagen 'Fortisil C'
Image source: Kalkine Media

Adroit Biomed Ltd., a pharmaceutical healthcare company is all set to launch its latest innovative technologically advanced, High-Performance Collagen, Fortisil C, a marine-based high performance collagen product that is set to revolutionize the skincare industry. Developed by leading scientists and skincare experts, Fortisil C is designed to rejuvenate and restore the skin for a youthful and radiant complexion, irrespective of their age or skin type.

Fortisil C

Collagen is a vital protein that helps to maintain the structure and elasticity of the skin, but as people age, their bodies produce less of it, leading to wrinkles, sagging skin, and other signs of aging. Fortisil C provides a potent and effective solution for improving skin health and appearance by using the power of marine collagen. With a unique formulation technology, Fortisil C is more effective at lower dosage of 2.5 gm. The product is available in effervescent form and 30 times more potent than standard collagen. It can improve skin hydration and skin elasticity within 2 months of usage because of its higher concentration of active dipeptides (Proli- hydroxyproline & Hydroxypoly - Glycine).

Fortisil C is very different from other collagen products available in the market because of its advanced formula, which includes a unique blend of amino acids, vitamins, and antioxidants that work together to nourish and replenish the skin. Additionally, each batch of Fortisil C is rigorously tested to make sure of its top-notch quality and purity, making it a safe and reliable choice for skincare enthusiasts. It's pocket friendly and convenient to carry.

Speaking on the occasion, Mr. Sushant Raorane, Co-founder and Director of Adroit Biomed Ltd. said, "Adroit Biomed Ltd. as a science-driven company, we take pride in offering innovative & exceptional quality products. Wellnex High Performance Collagen in Fortisil C formulated with unique proprietary technology. Fortisil C is disrupted the collagen market & clinically proven to be 30 times more effective at lower dosage. We are extremely proud to launch Fortisil C."

Dr Priya Talageri, Dermatologists said, "Currently available collagen products in the market have limited bioavailability & absorption. Today is the need of "High Performance Collagen" like Fortisil C."

Dr Anju Methil, Dermatologists also stated, "Patient treatment compliance depends upon overall appeal of the product. Fortisil C High-Performance Collagen don't have an obnoxious fishy smell like other collagen brands, which improves my patient compliance."

About Adroit Biomed Ltd.

Adroit Biomed Limited is a pharmaceutical healthcare company with a focus on dermato-cosmetology. As a science-driven company they offer exceptional quality products that inspire real change in the world of dermatology. These products are manufactured using the state-of-the-art formulation manufacturing facilities, adhering to international standards and regulations.

Using world class ingredients and the latest technology the company aims at delivering the highest quality products and forming an interface between innovation, technology, healthcare practitioners and patients.

Website: adroitbiomed.com.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.